Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Compare volatility and returns in retirement index funds to strike a balance between potential growth and risk control for sustainable withdrawals.
24,638 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
A major housing policy overhaul is poised to reshape mortgage lending as banks recalibrate underwriting and borrowers...
Apple reported a strong quarter with better-than-expected growth across iPhone and Services. Analysts say apple’s tar...
A federal lawsuit claims Kalibrate AI pricing software helps California gas stations coordinate higher pump prices, i...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
XRP steadies near $1 after a brutal June selloff, with two technical signals hinting at a short-term rebound. Analyst...
Pi Network’s PI token fell about 5% after Pi2Day hype, even as Bitcoin moved back to the $60,000 level. The market re...
A British TikTok star is entangled in a Dubai murder case, raising questions about legal costs, travel insurance, and...
Hometap expands its home equity investment offering to Georgia, Montana, Tennessee, Idaho, and Delaware, signaling co...
For California residents in the top tax brackets, the Invesco California AMT-Free Municipal Bond ETF PWZ continues to...
Nvidia stands at a crossroads: rising Chinese demand for AI GPUs could lift sales, but policy risks and fierce compet...